$20.35−0.09 (−0.44%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Sabra Healthcare REIT (SBRA) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~15.9%/yr (FY21→FY25), net margin 19.7%, and free cash flow (~$307.1M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Share count (+11.6%). Visible in the receipts below.
The lines that matter · FY21–FY25
Total revenue ($M)▲11.6%
787.5
FY21→FY25CAGR +15.9%/yr
Net income ($M)▲22.7%
155.5
one-off year: see footnoteCAGR —
Diluted EPS▲18.5%
0.64
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+11.6%
219.1mn → 244.5mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex
$41.5M
−24.1% YoY in FY25 · 5.3% of revenue.
Sabra Healthcare REIT Inc is reported by our data vendor in the format it uses for financial companies, so its lines are shown in the vendor's order under plain names, with no gross profit or operating income.
What the income statement says · FY21–FY25
Where the total revenue goes · FY25 ($M)
20¢ of every dollar of total revenue became net income in FY25.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
Sales and other revenue | — | 374,131.0 | 381,495.0 | 376,266.0 | 400,586.0 | — | ▼1.9% | −2.3% |
Account service charges | — | 356,883.0 | 284,581.0 | 236,153.0 | 186,672.0 | — | ▲25.4% | +24.1% |
Fees and service charges | — | 57,654.0 | 39,894.0 | 37,693.0 | 36,456.0 | — | ▲44.5% | +16.5% |
Investment income and gains | — | −1,154.0 | 0.0 | −1,541.0 | −411.0 | — | — | — |
Revenue before interest | — | 787,514.0 | 705,970.0 | 648,571.0 | 623,303.0 | — | ▲11.6% | +8.1% |
Interest on long-term debt | — | — | — | — | 105,471.0 | — | — | — |
Interest expense | — | 0.0 | 0.0 | 0.0 | 105,471.0 | — | — | — |
Total revenue | 912,356.0 | 787,514.0 | 705,970.0 | 648,571.0 | 517,832.0 | 436,664.0 | ▲11.6% | +15.9% |
Provision for credit losses | — | −1,047.0 | −571.0 | 191.0 | 141.0 | — | ▼83.4% | — |
Other operating expenses | — | 53,710.0 | 50,067.0 | 47,472.0 | 39,574.0 | — | ▲7.3% | +10.7% |
Depreciation | — | 186,996.0 | 169,623.0 | 183,087.0 | 187,782.0 | — | ▲10.2% | −0.1% |
Impairment charges | — | 7,322.0 | 18,472.0 | 14,332.0 | 94,042.0 | — | ▼60.4% | −57.3% |
Other special charges | — | 383,595.0 | 342,360.0 | 308,209.0 | 162,613.0 | — | ▲12.0% | +33.1% |
Operating expenses | — | 631,623.0 | 580,522.0 | 553,100.0 | 484,011.0 | — | ▲8.8% | +9.3% |
Non-operating income, net | — | −3,519.0 | 2,095.0 | −76,625.0 | −12,011.0 | — | — | — |
Pretax income | 65,017.0 | 153,419.0 | 128,114.0 | 18,655.0 | 21,669.0 | 80,670.0 | ▲19.8% | +17.4% |
Income tax | 1,766.0 | 1,837.0 | 1,005.0 | 2,002.0 | 1,242.0 | 1,845.0 | ▲82.8% | −0.1% |
Net income from continuing operations | — | 151,582.0 | 127,109.0 | 16,653.0 | 20,427.0 | — | ▲19.3% | +95.1% |
Other adjustments to net income | — | 3,928.0 | −397.0 | −2,897.0 | −98,032.0 | — | — | — |
Net income | 71,269.0 | 155,510.0 | 126,712.0 | 13,756.0 | −77,605.0 | −113,256.0 | ▲22.7% | — |
Diluted EPS | 0.28 | 0.64 | 0.54 | 0.06 | −0.34 | −0.52 | ▲18.5% | — |
Diluted shares (mn) | 259.82 | 244.50 | 236.05 | 232.79 | 230.95 | 219.07 | ▲3.6% | +2.8% |
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was 11% vs a 2% norm for this window, likely a one-time item; see the filing.FY21: This year's lines from our data vendor do not add up, so only totals are shown.TTM: The trailing twelve months' lines from our data vendor do not add up, so only totals are shown.
5 more years of statements and CSV export are on Premium, and 10 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-12 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Sabra Healthcare REIT's revenue last fiscal year?
Sabra Healthcare REIT reported revenue of $787.5M in fiscal 2025, up 11.6% from fiscal 2024.
What was Sabra Healthcare REIT's net income?
Sabra Healthcare REIT reported net income of $155.5M in fiscal 2025, a net margin of 19.7%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

